Figure 4. Establishment and assessment of immune-related prognostic signature. (A, B) 294 DGEs determined using (A) LASSO regression analysis and (B) 10-fold cross-validation. (C–E) The distribution of (C) risk score, (D) survival status, and (E) immune-related gene expression profiles.